+ Blood and lymphatic system disorders | Blood | Current |
+ Cardiac disorders | Card | Current |
+ Congenital, familial and genetic disorders | Cong | Current |
+ Ear and labyrinth disorders | Ear | Current |
+ Endocrine disorders | Endo | Current |
+ Eye disorders | Eye | Current |
+ Gastrointestinal disorders | Gastr | Current |
+ General disorders and administration site conditions | Genrl | Current |
+ Hepatobiliary disorders | Hepat | Current |
+ Immune system disorders | Immun | Current |
+ Infections and infestations | Infec | Current |
+ Injury, poisoning and procedural complications | Inj&P | Current |
+ Investigations | Inv | Current |
+ Metabolism and nutrition disorders | Metab | Current |
+ Musculoskeletal and connective tissue disorders | Musc | Current |
- Neoplasms benign, malignant and unspecified (incl cysts and polyps) | Neopl | Current |
+ Breast neoplasms benign (incl nipple) | | Current |
- Breast neoplasms malignant and unspecified (incl nipple) | | Current |
- Breast and nipple neoplasms malignant | | Current |
+ Apocrine breast carcinoma | | Current |
+ Breast angiosarcoma | | Current |
+ Breast angiosarcoma metastatic | | Current |
+ Breast cancer | | Current |
+ Breast cancer female | | Current |
+ Breast cancer in situ | | Current |
+ Breast cancer male | | Current |
+ Breast cancer metastatic | | Current |
+ Breast cancer recurrent | | Current |
+ Breast cancer stage I | | Current |
+ Breast cancer stage II | | Current |
+ Breast cancer stage III | | Current |
+ Breast cancer stage IV | | Current |
+ Breast sarcoma | | Current |
+ Breast sarcoma metastatic | | Current |
+ Breast sarcoma recurrent | | Current |
+ HER-2 positive breast cancer | | Current |
+ Hormone refractory breast cancer | | Current |
+ Inflammatory carcinoma of breast recurrent | | Current |
+ Inflammatory carcinoma of breast stage III | | Current |
+ Inflammatory carcinoma of breast stage IV | | Current |
+ Inflammatory carcinoma of the breast | | Current |
+ Intraductal papillary breast neoplasm | | Current |
+ Intraductal proliferative breast lesion | | Current |
+ Invasive breast carcinoma | | Current |
+ Invasive ductal breast carcinoma | | Current |
+ Invasive lobular breast carcinoma | | Current |
+ Invasive papillary breast carcinoma | | Current |
+ Lobular breast carcinoma in situ | | Current |
+ Malignant nipple neoplasm | | Current |
+ Malignant nipple neoplasm female | | Current |
+ Malignant nipple neoplasm male | | Current |
+ Medullary carcinoma of breast | | Current |
+ Metaplastic breast carcinoma | | Current |
+ Mucinous breast carcinoma | | Current |
+ Neuroendocrine breast tumour | | Current |
+ Oestrogen receptor positive breast cancer | | Current |
+ Paget's disease of nipple | | Current |
+ Squamous cell breast carcinoma | | Current |
+ Triple negative breast cancer | | Current |
+ Tubular breast carcinoma | | Current |
- Breast neoplasms unspecified malignancy | | Current |
+ Breast neoplasm | | Current |
+ Nipple neoplasm | | Current |
+ Phyllodes tumour | | Current |
+ Cancer-related morbidities | | Non-Current |
+ Cutaneous neoplasms benign | | Current |
+ Endocrine neoplasms benign | | Current |
+ Endocrine neoplasms malignant and unspecified | | Current |
+ Gastrointestinal neoplasms benign | | Current |
+ Gastrointestinal neoplasms malignant and unspecified | | Current |
+ Haematopoietic neoplasms (excl leukaemias and lymphomas) | | Current |
+ Hepatic and biliary neoplasms benign | | Current |
+ Hepatobiliary neoplasms malignant and unspecified | | Current |
+ Leukaemias | | Current |
+ Lymphomas Hodgkin's disease | | Current |
+ Lymphomas NEC | | Current |
+ Lymphomas non-Hodgkin's B-cell | | Current |
+ Lymphomas non-Hodgkin's T-cell | | Current |
+ Lymphomas non-Hodgkin's unspecified histology | | Current |
- Mesotheliomas | | Current |
+ Mesotheliomas benign | | Current |
+ Mesotheliomas malignant and unspecified | | Current |
+ Metastases | | Current |
+ Miscellaneous and site unspecified neoplasms benign | | Current |
+ Miscellaneous and site unspecified neoplasms malignant and unspecified | | Current |
+ Neoplasm related morbidities | | Current |
+ Nervous system neoplasms benign | | Current |
+ Nervous system neoplasms malignant and unspecified NEC | | Current |
+ Ocular neoplasms | | Current |
- Plasma cell neoplasms | | Current |
+ Multiple myelomas | | Current |
+ Plasma cell myelomas | | Current |
+ Plasma cell neoplasms NEC | | Current |
+ Renal and urinary tract neoplasms benign | | Current |
- Renal and urinary tract neoplasms malignant and unspecified | | Current |
- Bladder neoplasms malignant | | Current |
+ Bladder adenocarcinoma recurrent | | Current |
+ Bladder adenocarcinoma stage 0 | | Current |
- Bladder adenocarcinoma stage I | | Current |
+ Adenocarcinoma with squamous cell carcinoma of the bladder stage I | | Current |
+ Bladder adenocarcinoma stage II | | Current |
+ Bladder adenocarcinoma stage III | | Current |
+ Bladder adenocarcinoma stage IV | | Current |
+ Bladder adenocarcinoma stage unspecified | | Current |
+ Bladder cancer | | Current |
+ Bladder cancer recurrent | | Current |
+ Bladder cancer stage 0, with cancer in situ | | Current |
+ Bladder cancer stage 0, without cancer in situ | | Current |
+ Bladder cancer stage I, with cancer in situ | | Current |
+ Bladder cancer stage I, without cancer in situ | | Current |
+ Bladder cancer stage II | | Current |
+ Bladder cancer stage III | | Current |
+ Bladder cancer stage IV | | Current |
+ Bladder squamous cell carcinoma recurrent | | Current |
+ Bladder squamous cell carcinoma stage 0 | | Current |
+ Bladder squamous cell carcinoma stage I | | Current |
+ Bladder squamous cell carcinoma stage II | | Current |
+ Bladder squamous cell carcinoma stage III | | Current |
+ Bladder squamous cell carcinoma stage IV | | Current |
+ Bladder squamous cell carcinoma stage unspecified | | Current |
+ Bladder transitional cell carcinoma | | Current |
+ Bladder transitional cell carcinoma metastatic | | Current |
+ Bladder transitional cell carcinoma recurrent | | Current |
+ Bladder transitional cell carcinoma stage 0 | | Current |
+ Bladder transitional cell carcinoma stage I | | Current |
+ Bladder transitional cell carcinoma stage II | | Current |
+ Bladder transitional cell carcinoma stage III | | Current |
+ Bladder transitional cell carcinoma stage IV | | Current |
+ Metastatic carcinoma of the bladder | | Current |
+ Neuroendocrine carcinoma of the bladder | | Current |
+ Non-renal cell kidney neoplasms malignant | | Non-Current |
+ Renal cell carcinomas | | Non-Current |
+ Renal neoplasms malignant | | Current |
+ Renal pelvis and ureter neoplasms malignant | | Current |
+ Urinary tract neoplasms malignant NEC | | Current |
+ Urinary tract neoplasms unspecified malignancy NEC | | Current |
+ Reproductive and genitourinary neoplasms gender unspecified NEC | | Current |
+ Reproductive neoplasms female benign | | Current |
+ Reproductive neoplasms female malignant and unspecified | | Current |
+ Reproductive neoplasms male benign | | Current |
+ Reproductive neoplasms male malignant and unspecified | | Current |
+ Respiratory and mediastinal neoplasms benign (excl mesotheliomas) | | Current |
- Respiratory and mediastinal neoplasms malignant and unspecified | | Current |
+ Hypopharyngeal neoplasms malignant and unspecified | | Current |
+ Laryngeal neoplasms malignancy unspecified | | Current |
+ Laryngeal neoplasms malignant | | Current |
+ Mediastinal neoplasms malignancy unspecified NEC | | Current |
+ Mediastinal neoplasms malignant | | Current |
+ Non-small cell neoplasms malignant of the respiratory tract cell type specified | | Current |
+ Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecified | | Current |
+ Paranasal sinus and nasal cavity neoplasms malignant and unspecified | | Current |
+ Pharyngeal neoplasms malignant and unspecified | | Current |
+ Respiratory tract and pleural neoplasms malignancy unspecified NEC | | Current |
+ Respiratory tract and pleural neoplasms malignant cell type unspecified NEC | | Current |
+ Respiratory tract small cell carcinomas | | Current |
+ Skeletal neoplasms benign | | Current |
+ Skeletal neoplasms malignant and unspecified | | Current |
+ Skin neoplasms malignant and unspecified | | Current |
+ Soft tissue neoplasms benign | | Current |
+ Soft tissue neoplasms malignant and unspecified | | Current |
+ Soft tissue neoplasms malignant and unspecified (excl sarcomas) | | Current |
+ Soft tissue sarcomas | | Current |
+ Nervous system disorders | Nerv | Current |
+ Pregnancy, puerperium and perinatal conditions | Preg | Current |
+ Product issues | Prod | Current |
+ Psychiatric disorders | Psych | Current |
+ Renal and urinary disorders | Renal | Current |
+ Reproductive system and breast disorders | Repro | Current |
+ Respiratory, thoracic and mediastinal disorders | Resp | Current |
+ Skin and subcutaneous tissue disorders | Skin | Current |
+ Social circumstances | SocCi | Current |
+ Surgical and medical procedures | Surg | Current |
+ Vascular disorders | Vasc | Current |
Standard View
|